Our group demonstrated the early expression of CD169 in COVID-19 patients correlated with senescence and exhaustion markers in the CD8 T cell subset, as well as with B cell maturation and differentiation markers [60]. This evidence concerns the gene SIGLEC1 and COVID-19.